It’s known that the US Food and Drug Administration needs more information to determine whether hemp-derived cannabinoids are safe for dietary supplements. It also should be known, says acting Commissioner Janet Woodcock, that the agency needs to evaluate its oversight of all supplement manufacturing and marketing.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?